Copyright
©2010 Baishideng. All rights reserved.
World J Gastroenterol. Jan 14, 2010; 16(2): 156-166
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.156
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.156
Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance
Samuel Wolf, Jana Lorenz, Joachim Mössner, Marcus Wiedmann, Department of Internal Medicine II, University of Leipzig, Liebigstr. 20, 04103 Leipzig, Germany
Marcus Wiedmann, Department of Internal Medicine I, St. Mary’s Hospital, Gallwitzallee 123-143, 12249 Berlin, Germany
Author contributions: Wiedmann M designed the research and wrote the paper; Wolf S and Lorenz J performed the research; Mössner J analyzed the data and corrected the manuscript.
Supported by Grant No. 934000-258 from Novartis Oncology (to Wiedmann M)
Correspondence to: Dr. Marcus Wiedmann, PhD, Department of Internal Medicine I, St. Mary’s Hospital, Gallwitzallee 123-143, 12249 Berlin, Germany. wiedmann@marienkrankenhaus-berlin.de
Telephone: +49-30-76783251 Fax: +49-30-76783425
Received: September 7, 2009
Revised: November 2, 2009
Accepted: November 9, 2009
Published online: January 14, 2010
Revised: November 2, 2009
Accepted: November 9, 2009
Published online: January 14, 2010
Core Tip